At the last check on Thursday, Applied Therapeutics Inc.’s (NASDAQ:APLT) stock was down -$0.27, moving down -24.97 percent to $0.80. The average number of shares traded per day over the past five days has been 541,137 shares. 4 times new highs have been achieved over the past 5 days, with a -$0.2922 fall in that time frame. In the last twenty days, the average volume was 277,134, while in the previous 50 days, it was 212,180.
Since last month, APLT stock retreated -25.69%. Shares of the company fell to $0.7401 on 06/23/22, the lowest level in the past month. A 52-week high of $25.59 was reached on 01/03/22 after having rallying from a 52-week low of $0.99. Since the beginning of this year, APLT’s stock price has dropped by -88.04% or -$8.1422, and marked a new high 1 time. However, the stock has declined by -96.86% since its 52-week high.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free.
Applied Therapeutics Inc. (APLT) last reported insider trading activity 38 days ago on May 16. Mahadevan Chids disposed of 905 shares for $1.65 on May 16. It resulted in a $1,493 divestment by the insider. Perfetti Riccardo added 30,000 shares at an average price of $1.97 on Mar 23. The insider now owns 160,909 shares following the transaction. On Mar 22, Chief Medical Officer Perfetti Riccardo bought 21,961 shares at $1.98 apiece. The transaction was valued at $43,483.
In the three months ended March 30, Applied Therapeutics Inc.’s quick ratio stood at 2.90, while its current ratio was 2.90, showing that the company is able to pay off its debt.
While analysts expected Applied Therapeutics Inc. to report -$0.83 quarterly earnings, the actual figure was -$0.88 per share, beating the consensus estimate by -6.00%. The liabilities of Applied Therapeutics Inc. were 22.99 million at the end of its most recent quarter ended March 30, and its total debt was $2.12 million. The value of shareholders’ equity is $26.24 million.
This quick technical analysis looks at Applied Therapeutics Inc.’s (APLT) price momentum. With a historical volatility rate of 157.63%, the RSI 9-day stood at 23.03% on 22 June.
With respect to its five-day moving average, the current Applied Therapeutics Inc. price is down by -26.56% percent or -$0.2922. At present, APLT shares trade -45.05% below its 20-day simple moving average and -70.08% percent below its 100-day simple moving average. However, the stock is currently trading approximately -63.11% below its SMA50 and -94.75% below its SMA200.
Stochastic coefficient K was 13.22% and Stochastic coefficient D was 12.28%, while ATR was 0.1649. Given the Stochastic reading of 9.96% for the 14-day period, the RSI (14) reading has been calculated as 26.37%. As of today, the MACD Oscillator reading stands at -0.1200, while the 14-day reading stands at -0.1748.
Applied Therapeutics Inc. downgraded its rating on Applied Therapeutics Inc. (NASDAQ: APLT) to an Equal weight in a note to investors on January 04, 2022. The analysts firm previously had an Overweight rating on the stock.Applied Therapeutics Inc. (APLT) has been rated Overweight by analysts. According to 0 brokerage firms, APLT is a sell, and 1 firms recommend it is a Hold. There are 0 analysts who say the stock is underweight. A total of 1 analyst rate Applied Therapeutics Inc. stock as buy, with 2 recommending it as overweight.
With a median target price of $12.00, the current consensus forecast for the stock is $2.50 – $29.00. Based on these forecasts, analysts predict Applied Therapeutics Inc. (APLT) will achieve an average price target of $13.88.